1. Zhang, Ying-Yu, Fu, Zhen-Yan, Wei, Jian, Ma, Yi-Tong, Song, Bao-Liang. . A LIMA1 variant promotes low plasma LDL cholesterol and decreases intestinal cholesterol absorption. In Science (New York, N.Y.), 360, 1087-1092. doi:10.1126/science.aao6575. https://pubmed.ncbi.nlm.nih.gov/29880681/
2. Wang, Xiaoxiao, Zhang, Chao, Song, Huangqin, Zhang, Lei, He, Jiefeng. 2023. Characterization of LIMA1 and its emerging roles and potential therapeutic prospects in cancers. In Frontiers in oncology, 13, 1115943. doi:10.3389/fonc.2023.1115943. https://pubmed.ncbi.nlm.nih.gov/37274282/
3. Li, Shihui, Yang, Fuji, Cheng, Fang, Zhu, Ling, Yan, Yongmin. 2024. Lipotoxic hepatocyte derived LIMA1 enriched small extracellular vesicles promote hepatic stellate cells activation via inhibiting mitophagy. In Cellular & molecular biology letters, 29, 82. doi:10.1186/s11658-024-00596-4. https://pubmed.ncbi.nlm.nih.gov/38822260/
4. Ma, Wei, Liao, Yiqun, Gao, Ziwen, Liu, Jianbing, She, Wandong. 2022. Overexpression of LIMA1 Indicates Poor Prognosis and Promotes Epithelial-Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma. In Clinical Medicine Insights. Oncology, 16, 11795549221109493. doi:10.1177/11795549221109493. https://pubmed.ncbi.nlm.nih.gov/35837368/
5. Ohashi, Tomoko, Idogawa, Masashi, Sasaki, Yasushi, Tokino, Takashi. 2017. p53 mediates the suppression of cancer cell invasion by inducing LIMA1/EPLIN. In Cancer letters, 390, 58-66. doi:10.1016/j.canlet.2016.12.034. https://pubmed.ncbi.nlm.nih.gov/28093207/
智鼠故事 
